Answers are grounded in this paper and cite their sources.
In vitro study reveals concentration-dependent anthelmintic activity of tannic acid in earthworms, indicating its therapeutic potential as an antiparasitic agent.
ABSTRACT:Background: Helminthic infections continue to pose a significant public health challengeworldwide, particularly in developing countries, necessitating the exploration of safe andeffective alternative anthelmintic agents. Tannic acid, a naturally occurring polyphenoliccompound, has attracted considerable attention due to its diverse biological activities, includingpotential antiparasitic properties.Objective: The present study was undertaken to evaluate the in vitro anthelmintic efficacy oftannic acid against Pheretima posthuma and compare its activity with the standard anthelminticdrug, albendazole.Materials and Methods: Adult Indian earthworms (Pheretima posthuma) were exposed totannic acid at concentrations of 20, 40, and 60 mg/mL. Albendazole (20 mg/mL) served as thereference standard. Six worms were included in each treatment group (n = 6). Anthelminticactivity was assessed by recording the mean time required for paralysis and death of the worms.The results were expressed as mean ± SEM and analyzed using one-way ANOVA followed byDunnett's multiple comparison test.Results: Tannic acid exhibited a concentration-dependent anthelmintic effect. At 20 mg/mL,paralysis and death occurred at 6.200 ± 0.1897 min and 12.117 ± 0.1169 min, respectively.Increasing the concentration to 40 mg/mL reduced the paralysis and death times to 4.633 ±0.1506 min and 7.183 ± 0.1602 min, respectively. The highest concentration (60 mg/mL)produced the greatest activity, causing paralysis within 3.000 ± 0.1414 min and death within5.667 ± 0.0817 min, which was comparable to the standard albendazole (3.367 ± 0.1862 min and6.450 ± 0.1049 min, respectively).Conclusion: The findings demonstrate that tannic acid possesses significant concentration-dependent in vitro anthelmintic activity against Pheretima posthuma. Its efficacy at 60 mg/mLwas comparable to the standard drug, indicating that tannic acid may serve as a promising naturalcandidate for the development of novel anthelmintic agents. Further in vivo and mechanisticstudies are required to validate its therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Dasrao Ashok Patil, Dr. Kavaljit Satish Birajdar, Dr. Prashant Premnath Mane, Dhruti Prashant Mane, Suraj Sudhakar More, Suraj Dilip Bhagat (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: